Table 3.

Comparison of demographic, clinical, and laboratory features before initial treatment with IVIG in patients with incomplete and complete KD

Data are expressed as mean±SD. ^*p<0.05, ^†p of comparison between IVIG non-responders in the incomplete and complete KD group, ^‡Sampling day of illness: day of sampling calculated as days elapsed from the first day of illness. KD: Kawasaki disease, Non-responders: IVIG non-responders, Responders: IVIG responders, IVIG: intravenous immunoglobulin, WBC: white blood cell, SEG%: percentage of segmented neutrophils, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, TB: total bilirubin, AST: aspartate aminotransferase, ALT: alanine aminotransferase, NT-proBNP: N-terminal pro-B-type natriuretic peptide, GGT: gamma glutamyltransferase